Financial Performance Decline

Market sentiment has remained mixed. Over the past six months, CRK’s stock price fell 37.5 % to trade at $13.30 per share. The company’s long‑term revenue growth has been modest, with a 5.7 % compounded annual growth rate over the last five years, below industry benchmarks. Adjusted EBITDA margin declined by 6.1 percentage points to 72.2 % for the trailing 12 months, reflecting unchanged fixed costs. Free cash flow has been negative, averaging a margin of –9.1 % over the last five years, indicating significant cash burn and raising concerns about the company’s ability to return capital to investors or fund growth initiatives.